cancer of thyroid	is a	malignant neoplasm of thyroid
cancer of thyroid	is a	thyroid malignancy
papillary thyroid carcinoma	is a	cancer of thyroid
follicular thyroid carcinoma	is a	cancer of thyroid
medullary thyroid carcinoma	is a	cancer of thyroid
anaplastic thyroid carcinoma	is a	cancer of thyroid
cancer of thyroid	has histology	papillary thyroid carcinoma
cancer of thyroid	has histology	follicular thyroid carcinoma
cancer of thyroid	has histology	medullary thyroid carcinoma
cancer of thyroid	has histology	anaplastic thyroid carcinoma
cancer of thyroid	metastasizes to	lymph nodes
cancer of thyroid	metastasizes to	lungs
cancer of thyroid	metastasizes to	bones
cancer of thyroid	metastasizes to	liver
cancer of thyroid	metastasizes to	brain
papillary thyroid carcinoma	metastasizes to	cervical lymph nodes
follicular thyroid carcinoma	metastasizes to	bone
medullary thyroid carcinoma	metastasizes to	liver
anaplastic thyroid carcinoma	metastasizes to	brain
cancer of thyroid	treated with	thyroidectomy
cancer of thyroid	treated with	radioactive iodine therapy
cancer of thyroid	treated with	external beam radiotherapy
cancer of thyroid	treated with	chemotherapy
cancer of thyroid	treated with	targeted therapy
papillary thyroid carcinoma	treated with	thyroidectomy
follicular thyroid carcinoma	treated with	thyroidectomy
medullary thyroid carcinoma	treated with	thyroidectomy
anaplastic thyroid carcinoma	treated with	palliative care
medullary thyroid carcinoma	secretes	calcitonin
papillary thyroid carcinoma	secretes	thyroglobulin
follicular thyroid carcinoma	secretes	thyroglobulin
cancer of thyroid	is associated with	ionizing radiation
cancer of thyroid	is associated with	family history
ionizing radiation	is a risk factor for	cancer of thyroid
family history	is a risk factor for	cancer of thyroid
RET proto-oncogene mutation	is associated with	medullary thyroid carcinoma
RET proto-oncogene mutation	is associated with	MEN2 syndrome
BRAF mutation	is associated with	papillary thyroid carcinoma
RAS mutation	is associated with	follicular thyroid carcinoma
PTEN mutation	is associated with	cancer of thyroid
cancer of thyroid	diagnosed by	fine-needle aspiration
cancer of thyroid	diagnosed by	ultrasound
cancer of thyroid	diagnosed by	CT scan
cancer of thyroid	diagnosed by	MRI
cancer of thyroid	diagnosed by	biopsy
cancer of thyroid	confirmed by	histopathology
cancer of thyroid	has biomarker	thyroglobulin
medullary thyroid carcinoma	has biomarker	calcitonin
papillary thyroid carcinoma	has biomarker	thyroglobulin
follicular thyroid carcinoma	has biomarker	thyroglobulin
cancer of thyroid	prognosis depends on	stage
cancer of thyroid	prognosis depends on	age
papillary thyroid carcinoma	prognosis depends on	stage
follicular thyroid carcinoma	prognosis depends on	stage
medullary thyroid carcinoma	prognosis depends on	stage
anaplastic thyroid carcinoma	prognosis depends on	stage
cancer of thyroid	recurrence after	treatment
cancer of thyroid	recurrence	after surgery
papillary thyroid carcinoma	recurrence after	treatment
follicular thyroid carcinoma	recurrence after	treatment
medullary thyroid carcinoma	recurrence after	treatment
anaplastic thyroid carcinoma	recurrence after	treatment
cancer of thyroid	risk of	second primary cancer
differentiated thyroid cancer	risk of	distant metastasis
cancer of thyroid	prognosis depends on	stage
surgery	reduces	cancer of thyroid mass
neck dissection	reduces	lymph node metastasis
radioactive iodine therapy	requires	TSH stimulation
surgical removal	reduces	tumor burden
external beam radiotherapy	used for	palliation
margin status	indicates	prognosis
extrathyroidal extension	worsens	prognosis
lymph node involvement	worsens	prognosis
cervical lymph node metastasis	indicates	advanced disease
distant metastasis	indicates	stage IV disease
calcitonin	is a biomarker for	medullary thyroid carcinoma
thyroglobulin	is a biomarker for	differentiated thyroid cancer
differentiated thyroid cancer	responds to	iodine therapy
papillary thyroid carcinoma	responds to	iodine therapy
follicular thyroid carcinoma	responds to	radioiodine therapy
medullary thyroid carcinoma	does not respond well to	radioiodine therapy
anaplastic thyroid carcinoma	responds to	immunotherapy
cancer of thyroid	involves	cervical lymph nodes
cancer of thyroid	presents as	neck mass
neck mass	presents as	symptom of cancer of thyroid
papillary thyroid carcinoma	presents as	neck mass
anaplastic thyroid carcinoma	presents with	rapidly enlarging neck mass
cancer of thyroid	presents with	hoarseness
cancer of thyroid	presents with	dysphagia
cancer of thyroid	presents with	throat pain
radiation exposure	increases risk of	cancer of thyroid
Hashimoto thyroiditis	associated with	cancer of thyroid
BRAF mutation	seen in	papillary thyroid carcinoma
RAS mutation	seen in	follicular thyroid carcinoma
RET mutation	seen in	medullary thyroid carcinoma
RET proto-oncogene mutation	present in	MEN2 syndrome
MEN2 syndrome	includes	medullary thyroid carcinoma
p53 mutation	seen in	anaplastic thyroid carcinoma
undifferentiated thyroid carcinoma	classified as	anaplastic thyroid carcinoma
radioiodine refractory cancer of thyroid	requires	alternative therapy
